Literature DB >> 29730006

Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site.

Manju Narwal1, Harvijay Singh1, Shivendra Pratap1, Anjali Malik1, Richard J Kuhn2, Pravindra Kumar1, Shailly Tomar3.   

Abstract

Chikungunya virus (CHIKV), a mosquito-borne pathogenic alphavirus is a growing public health threat. No vaccines or antiviral drug is currently available in the market for chikungunya treatment. nsP2pro, the viral cysteine protease, carries out an essential function of nonstructural polyprotein processing and forms four nonstructural proteins (nsPs) that makes the replication complex, hence constitute a promising drug target. In this study, crystal structure of nsP2pro has been determined at 2.59 Å, which reveals that the protein consists of two subdomains: an N-terminal protease subdomain and a C-terminal methyltransferase subdomain. Structural comparison of CHIKV nsP2pro with structures of other alphavirus nsP2 advances that the substrate binding cleft is present at the interface of two subdomains. Additionally, structure insights revealed that access to the active site and substrate binding cleft is blocked by a flexible interdomain loop in CHIKV nsP2pro. This loop contains His548, the catalytic residue, and Trp549 and Asn547, the residues predicted to bind substrate. Interestingly, mutation of Asn547 leads to three-fold increase in Km confirming that Asn547 plays important role in substrate binding and recognition. This study presents the detailed molecular analysis and signifies the substrate specificity residues of CHIKV nsP2pro, which will be beneficial for structure-based drug design and optimization of CHIKV protease inhibitors.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active site blockade; Chikungunya virus; Cysteine protease; FRET assay; Plus-strand RNA virus

Mesh:

Substances:

Year:  2018        PMID: 29730006     DOI: 10.1016/j.ijbiomac.2018.05.007

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  13 in total

1.  Structural insights into RNA recognition by the Chikungunya virus nsP2 helicase.

Authors:  Yee-Song Law; Age Utt; Yaw Bia Tan; Jie Zheng; Sainan Wang; Ming Wei Chen; Patrick R Griffin; Andres Merits; Dahai Luo
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-18       Impact factor: 11.205

Review 2.  A review on structural genomics approach applied for drug discovery against three vector-borne viral diseases: Dengue, Chikungunya and Zika.

Authors:  Shobana Sundar; Shanmughavel Piramanayagam; Jeyakumar Natarajan
Journal:  Virus Genes       Date:  2022-04-08       Impact factor: 2.332

3.  Phage-Related Ribosomal Protease (Prp) of Staphylococcus aureus: In Vitro Michaelis-Menten Kinetics, Screening for Inhibitors, and Crystal Structure of a Covalent Inhibition Product Complex.

Authors:  Julia A Hotinger; Heather A Pendergrass; Darrell Peterson; H Tonie Wright; Aaron E May
Journal:  Biochemistry       Date:  2022-06-22       Impact factor: 3.321

4.  Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches.

Authors:  Vitor Won-Held Rabelo; Izabel Christina Nunes de Palmer Paixão; Paula Alvarez Abreu
Journal:  J Mol Model       Date:  2022-09-12       Impact factor: 2.172

5.  Interdomain Flexibility of Chikungunya Virus nsP2 Helicase-Protease Differentially Influences Viral RNA Replication and Infectivity.

Authors:  Yee-Song Law; Sainan Wang; Yaw Bia Tan; Orion Shih; Age Utt; Wei Yang Goh; Bing-Jun Lian; Ming Wei Chen; U-Ser Jeng; Andres Merits; Dahai Luo
Journal:  J Virol       Date:  2021-02-24       Impact factor: 5.103

6.  Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.

Authors:  Larisa Ivanova; Kai Rausalu; Maksim Ošeka; Dzmitry G Kananovich; Eva Žusinaite; Jaana Tammiku-Taul; Margus Lopp; Andres Merits; Mati Karelson
Journal:  ACS Omega       Date:  2021-04-14

7.  Targeting the nsp2 Cysteine Protease of Chikungunya Virus Using FDA Approved Library and Selected Cysteine Protease Inhibitors.

Authors:  Prateek Kumar; Deepak Kumar; Rajanish Giri
Journal:  Pathogens       Date:  2019-08-15

8.  Semliki Forest Virus Chimeras with Functional Replicase Modules from Related Alphaviruses Survive by Adaptive Mutations in Functionally Important Hot Spots.

Authors:  Mona Teppor; Eva Žusinaite; Liis Karo-Astover; Ailar Omler; Kai Rausalu; Valeria Lulla; Aleksei Lulla; Andres Merits
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

Review 9.  Small-Molecule Inhibitors of Chikungunya Virus: Mechanisms of Action and Antiviral Drug Resistance.

Authors:  Kristina Kovacikova; Martijn J van Hemert
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

10.  Turnip yellow mosaic virus protease binds ubiquitin suboptimally to fine-tune its deubiquitinase activity.

Authors:  Sonia Fieulaine; Martin D Witte; Christopher S Theile; Maya Ayach; Hidde L Ploegh; Isabelle Jupin; Stéphane Bressanelli
Journal:  J Biol Chem       Date:  2020-07-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.